Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Weight Management
Recent news which mentions Weight Management
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
December 24, 2024
Tags
US: News
Business
Pharmaceuticals
From
CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
December 08, 2024
Tags
LILLY DRN
Crime
Weight management
From
CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
December 05, 2024
Tags
Biotechnology
Companies
Social issues
From
CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
December 04, 2024
Tags
Health care industry
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
Tags
Weight management
Business News
LILLY DRN
From
CNBC.com News
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
September 12, 2024
Tags
Enterprise
Pharmaceuticals
Breaking News: Technology
From
CNBC.com News
If you invested $1,000 in drugmaker Eli Lilly 10 years ago, here's how much money you'd have now
August 08, 2024
Tags
Stock markets
Weight management
Make It / Save and Invest
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Investing
Markets
Diabetes
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Novo Nordisk A/S
Small business
Employee healthcare benefits
From
CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
March 16, 2024
Tags
Social issues
Weight management
Business News
From
CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
February 28, 2024
Tags
WW International Inc
Medifast Inc
Health care industry
From
CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
February 28, 2024
Tickers
CATS
DOGS
PETS
Tags
Cats
Eli Lilly and Co
Pfizer Inc
From
CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
February 16, 2024
Tags
Health insurance
Weight management
Health Insurance
From
CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
February 10, 2024
Tags
Business
US: News
Health & Science
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
Health care industry
Altimmune Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
Tags
Science
Health & Science
Pfizer Inc
From
CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
Tags
Breaking News: Earnings
Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
October 24, 2023
Tags
Mobile
Alphabet Inc
Health care industry
From
CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Stock markets
Medication
Biotechnology
From
CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
October 10, 2023
Tickers
CEO
Tags
US: News
CEO
Business
From
CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
September 27, 2023
Tags
Companies
Biotechnology
Breaking news
From
CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
Tags
Science
Health & Science
Eli Lilly and Co
From
CNBC.com News
Ozempic could be the next target of Medicare drug price negotiations – here's why
August 31, 2023
Tags
Breaking news
Medicare health plans
Companies
From
CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
August 21, 2023
Tags
Breaking News: Business
Medication
Novo Nordisk A/S
From
CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
August 16, 2023
Tags
Novo Nordisk A/S
Breaking news
Weight loss diets
From
CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
August 10, 2023
Tags
Health care industry
Deals & IPOs
Biotech and Pharmaceuticals
From
CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
August 09, 2023
Tags
Health care industry
Diabetes
Business News
From
CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
July 27, 2023
Tags
Weight management
Clinical trials
Business News
From
CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
July 26, 2023
Tags
Biotech and Pharmaceuticals
Suicides
Health care industry
From
CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
July 14, 2023
Tags
Pharmaceuticals
Eli Lilly and Co
Science
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit